These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1300204)

  • 1. Exploratory data analytic techniques to evaluate anticancer agents screened in a cell culture panel.
    Hodes L; Paull K; Koutsoukos A; Rubinstein L
    J Biopharm Stat; 1992; 2(1):31-48. PubMed ID: 1300204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCI's anticancer drug screening program may not be selecting for clinically active compounds.
    Brown JM
    Oncol Res; 1997; 9(5):213-5. PubMed ID: 9306428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structural characterization, and in vitro antitumor activity of novel N-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)arylsulfonamides.
    Brzozowski Z; Saczewski F; Sławiński J; Bednarski PJ; Grünert R; Gdaniec M
    Bioorg Med Chem; 2007 Apr; 15(7):2560-72. PubMed ID: 17306551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic effect of 2,3-disubstituted chromanones in human cancer cell lines.
    Vanangamudi A; Sudhakar S; Gandhidasan R
    Indian J Exp Biol; 1999 Feb; 37(2):173-5. PubMed ID: 10641138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data.
    Paull KD; Lin CM; Malspeis L; Hamel E
    Cancer Res; 1992 Jul; 52(14):3892-900. PubMed ID: 1617665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
    Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of S-dialkylarsino-3-mercapto-1,2-propanediols and evaluation of their anticancer activity.
    Gao M; Tan S; Chen Y; Zingaro RA
    Bioorg Med Chem; 2007 Apr; 15(7):2660-6. PubMed ID: 17287125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of anticancer activity of 2-arylamino-6-trifluoromethyl-3-(hydrazonocarbonyl)pyridines.
    Onnis V; Cocco MT; Fadda R; Congiu C
    Bioorg Med Chem; 2009 Sep; 17(17):6158-65. PubMed ID: 19679483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic assays for screening anticancer agents.
    Baharith LA; Al-Khouli A; Raab GM
    Stat Med; 2006 Jul; 25(13):2323-39. PubMed ID: 16013035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibitory effect of diheptyl diselenide on various human cancer cell lines.
    Scambia G; Panici PB; Battaglia F; Ferrandina G; Gaggini C; Mancuso S
    Anticancer Res; 1989; 9(6):1697-9. PubMed ID: 2627122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 11-substituted 6-aminobenzo[c]phenanthridine derivatives, a new class of antitumor agents.
    Kock I; Heber D; Weide M; Wolschendorf U; Clement B
    J Med Chem; 2005 Apr; 48(8):2772-7. PubMed ID: 15828815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural revision of sulfated polysaccharide B-1 isolated from a marine Pseudomonas species and its cytotoxic activity against human cancer cell lines.
    Matsuda M; Yamori T; Naitoh M; Okutani K
    Mar Biotechnol (NY); 2003; 5(1):13-9. PubMed ID: 12925914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.
    Pratesi G; De Cesare M; Carenini N; Perego P; Righetti SC; Cucco C; Merlini L; Pisano C; Penco S; Carminati P; Vesci L; Zunino F
    Clin Cancer Res; 2002 Dec; 8(12):3904-9. PubMed ID: 12473606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues.
    Congiu C; Cocco MT; Onnis V
    Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione.
    El-Hawash SA; Wahab AE
    Arch Pharm (Weinheim); 2006 Aug; 339(8):437-47. PubMed ID: 16881038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.
    Yip KW; Mao X; Au PY; Hedley DW; Chow S; Dalili S; Mocanu JD; Bastianutto C; Schimmer A; Liu FF
    Clin Cancer Res; 2006 Sep; 12(18):5557-69. PubMed ID: 17000693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer activity of natural cytokinins: a structure-activity relationship study.
    Voller J; Zatloukal M; Lenobel R; Dolezal K; Béres T; Krystof V; Spíchal L; Niemann P; Dzubák P; Hajdúch M; Strnad M
    Phytochemistry; 2010 Aug; 71(11-12):1350-9. PubMed ID: 20553699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells.
    Drees M; Dengler WA; Roth T; Labonte H; Mayo J; Malspeis L; Grever M; Sausville EA; Fiebig HH
    Clin Cancer Res; 1997 Feb; 3(2):273-9. PubMed ID: 9815683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of anticancer agents by their growth inhibitory activity and relationships to mechanism of action and structure.
    Keskin O; Bahar I; Jernigan RL; Beutler JA; Shoemaker RH; Sausville EA; Covell DG
    Anticancer Drug Des; 2000 Apr; 15(2):79-98. PubMed ID: 10901296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
    Csuk R; Schwarz S; Kluge R; Ströhl D
    Eur J Med Chem; 2010 Dec; 45(12):5718-23. PubMed ID: 20884085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.